Loading the map…
Other human health activities · Lincoln, Lincolnshire
Ad Therapy
Ad Therapy Ltd
Private limited company registered in Lincoln, classed under “Other human health activities”.
Headline figures
FY to Mar 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
1 finding from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2024 | 2025 |
|---|---|---|
| Profit after tax | — | |
| Turnover | ||
| Net assets | ||
| Cash | ||
| Employees |
Every figure for all 2 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2024 | 2025 |
|---|---|---|
| Current assets | ||
| Creditors due within a year | ||
| Net current assets | ||
| Net assets | ||
| Ratios | ||
| Current ratioCurrent assets for every £1 owed within a year | ||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||
4 balance-sheet lines and 2 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Ad Therapy do?
Private limited company registered in Lincoln, classed under “Other human health activities”.
›How much turnover does Ad Therapy make?
Answered in the full report
›Is Ad Therapy profitable?
Ad Therapy's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Ad Therapy?
Answered in the full report
›Where is Ad Therapy based?
Its registered office is Brunswick House 86-88, Carholme Road, Lincoln, Lincolnshire, LN1 1SP, in Lincoln, Lincolnshire.
›When was Ad Therapy founded?
Ad Therapy Ltd was incorporated on 7 March 2023.
›Is Ad Therapy still trading?
The register lists Ad Therapy Ltd as active.